CAS 953778-58-0

Fórmula: C20H23F3N2O2

InChI: InChI=1S/C20H23F3N2O2/c1-13(2)16-6-4-15(5-7-16)10-19(26)25-14(3)18-9-8-17(11-24-18)27-12-20(21,22)23/h4-9,11,13-14H,10,12H2,1-3H3,(H,25,26)/t14-/m1/s1

Chave InChI: IQIKXZMPPBEWAD-CQSZACIVSA-N

SMILES: C[C@H](C1=NC=C(C=C1)OCC(F)(F)F)NC(=O)CC2=CC=C(C=C2)C(C)C

(R)-2-(4-Isopropylphenyl)-N-(1-(5-(2,2,2-Trifluoroethoxy)pyridin-2-yl)Ethyl)AcetaMide

CAS: 953778-58-0

(R)-2-(4-Isopropylphenyl)-N-(1-(5-(2,2,2-Trifluoroethoxy)pyridin-2-yl)Ethyl)AcetaMide

Fórmula: C₂₀H₂₃F₃N₂O₂

Pureza: ≥98%

Peso molecular: 380.4

Ref: 54-PC108725

Suvecaltamide

CAS: 953778-58-0

Suvecaltamide

Fórmula: C₂₀H₂₃F₃N₂O₂

Pureza: 99.5%

Peso molecular: 380.4

Ref: 54-BUP13216

4-(1-Methylethyl)-N-[(1R)-1-[5-(2,2,2-trifluoroethoxy)-2-pyridinyl]ethyl]benzeneacetamide

CAS: 953778-58-0

Fórmula: C₂₀H₂₃F₃N₂O₂

Pureza: 99%

Cor e Forma: Solid

Peso molecular: 380.4040

Ref: IN-DA01EB1A

Suvecaltamide

CAS: 953778-58-0

Suvecaltamide (MK-8998) as potent inhibitors of T-type calcium channels.

Fórmula: C₂₀H₂₃F₃N₂O₂

Pureza: 99.29% - 99.70%

Cor e Forma: White Solid

Peso molecular: 380.404

Ref: TM-T5632

MK-8998

CAS: 953778-58-0

MK-8998 is a drug that blocks the calcium channel and has been investigated as a potential treatment for psychosis. MK-8998 has been found to be effective in reducing symptoms of psychosis in patients with schizophrenia, bipolar disorder, and major depressive disorder. The mechanism of action is thought to be related to its ability to block the calcium channels in the brain, thereby inhibiting neuronal activity. MK-8998 has been shown to have selectivity for the alpha2A subtype of voltage-gated calcium channels (L-, N-, P/Q-, R-, T-) but not the alpha1 or alpha2B subtypes. In vitro studies have demonstrated that MK-8998 inhibits currents through L-, N-, P/Q-, R-, and T-type channels with IC50 values ranging from 0.5 nM to 1 μM.

Fórmula: C₂₀H₂₃F₃N₂O₂

Pureza: Min. 95%

Peso molecular: 380.4 g/mol

Ref: 3D-DNB77858